IDBONY
AMRX icon

Israel Discount Bank of New York’s Amneal Pharmaceuticals AMRX Stock Holding History

Israel Discount Bank of New York’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-985
Closed -$14K – 98
2019
Q1 		$14K Hold
985
– – 0.01% 358
2018
Q4 		$13K Hold
985
– – 0.01% 361
2018
Q3 		$22K Buy
+985
New +$20.7K 0.01% 333

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Discount Bank of New York's AMRX Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 985 shares — an estimated $14K sold.

Israel Discount Bank of New York first reported a position in AMRX in Q3 2018 and held it in 3 quarters. The position peaked at $22K in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • Israel Discount Bank of New York reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Israel Discount Bank of New York sold 985 Amneal Pharmaceuticals shares in Q2 2019, an estimated $14K.
  • Israel Discount Bank of New York first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Israel Discount Bank of New York's Amneal Pharmaceuticals position peaked at $22K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.